...
首页> 外文期刊>Malaria Journal >Cellular and humoral immune responses against the Plasmodium vivax MSP-119 malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil
【24h】

Cellular and humoral immune responses against the Plasmodium vivax MSP-119 malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil

机译:居住在巴西东北亚马逊地区流行区的人对间日疟原虫MSP-1 19 疟疾候选疫苗的细胞和体液免疫反应

获取原文

摘要

Background Plasmodium vivax merozoite surface protein-1 (MSP-1) is an antigen considered to be one of the leading malaria vaccine candidates. PvMSP-1 is highly immunogenic and evidences suggest that it is target for protective immunity against asexual blood stages of malaria parasites. Thus, this study aims to evaluate the acquired cellular and antibody immune responses against PvMSP-1 in individuals naturally exposed to malaria infections in a malaria-endemic area in the north-eastern Amazon region of Brazil. Methods The study was carried out in Paragominas, Pará State, in the Brazilian Amazon. Blood samples were collected from 35 individuals with uncomplicated malaria. Peripheral blood mononuclear cells were isolated and the cellular proliferation and activation was analysed in presence of 19 kDa fragment of MSP-1 (PvMSP-119) and Plasmodium falciparum PSS1 crude antigen. Antibodies IgE, IgM, IgG and IgG subclass and the levels of TNF, IFN-γ and IL-10 were measured by enzyme-linked immunosorbent assay. Results The prevalence of activated CD4+ was greater than CD8+ T cells, in both ex-vivo and in 96 h culture in presence of PvMSP-119 and PSS1 antigen. A low proliferative response against PvMSP-119 and PSS1 crude antigen after 96 h culture was observed. High plasmatic levels of IFN-γ and IL-10 as well as lower TNF levels were also detected in malaria patients. However, in the 96 h supernatant culture, the dynamics of cytokine responses differed from those depicted on plasma assays; in presence of PvMSP-119 stimulus, higher levels of TNF were noted in supernatant 96 h culture of malaria patient’s cells while low levels of IFN-γ and IL-10 were verified. High frequency of malaria patients presenting antibodies against PvMSP-119 was evidenced, regardless class or IgG subclass.PvMSP-119-induced antibodies were predominantly on non-cytophilic subclasses. Conclusions The results presented here shows that PvMSP-119 was able to induce a high cellular activation, leading to production of TNF and emphasizes the high immunogenicity of PvMSP-119 in naturally exposed individuals and, therefore, its potential as a malaria vaccine candidate.
机译:背景间日疟原虫裂殖子表面蛋白-1(MSP-1)是一种抗原,被认为是主要的疟疾疫苗候选者之一。 PvMSP-1具有高度免疫原性,证据表明它是针对疟原虫无性血液阶段的保护性免疫的靶标。因此,本研究旨在评估巴西东北亚马逊地区疟疾流行地区自然暴露于疟疾感染的个体对PvMSP-1获得的细胞和抗体免疫应答。方法该研究在巴西亚马逊州帕拉州的Paragominas进行。从35例无并发症的疟疾患者中采集血液样本。分离外周血单个核细胞,并在19kDa MSP-1片段(PvMSP-119)和恶性疟原虫PSS1粗抗原存在下分析细胞增殖和活化。通过酶联免疫吸附法测定抗体IgE,IgM,IgG和IgG亚类以及TNF,IFN-γ和IL-10的水平。结果在存在PvMSP-119和PSS1抗原的情况下,在离体和96 h培养中,活化的CD4 +的患病率均大于CD8 + T细胞。在96 h培养后,观察到针对PvMSP-119和PSS1粗抗原的低增殖反应。在疟疾患者中,血浆中的IFN-γ和IL-10含量较高,而TNF含量较低。然而,在96小时的上清液培养中,细胞因子反应的动力学不同于血浆分析中描述的动力学。在存在PvMSP-119刺激的情况下,在疟疾患者细胞96小时培养上清液中发现了更高水平的TNF,同时证实了低水平的IFN-γ和IL-10。无论是类别还是IgG亚类,都有证据显示疟疾患者呈递针对PvMSP-119的抗体的高频率.PvMSP-119诱导的抗体主要针对非嗜细胞性亚类。结论此处显示的结果表明,PvMSP-119能够诱导高细胞活化,从而导致TNF的产生,并强调了PvMSP-119在自然暴露的个体中的高免疫原性,因此,它具有作为疟疾疫苗候选者的潜力。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号